An Exam to the System of European Patents, Public Health and the Biotech and Pharmaceutical Industry (Un Examen al Sistema de Patentes Europeo, Salud Pública y la Industria Farmacéutica y Biotecnológica) (Spanish)

Revista la Propiedad Inmaterial, No. 14, pp. 49-58, 2010

10 Pages Posted: 9 Nov 2010

Date Written: November 8, 2010

Abstract

New technology, especially biotechnology and the creation of new medicines, represents a difficult legal task for the European Union (EU). There are interests that conflicts with each other: the protection of the internal market and health care, prevent and treat illness, ensure a competitive and sustainable future for the EU, and even more sovereignty of Member States. This essay aims to discus different legal aspects that surround the regulation on new technologies in the EU. It describes and analyses norms, bodies and conflicts between them. Special attention is paid to the European Patent System and the Marketing Authorization (MA).

Note: Downloadable document is in Spanish.

Keywords: New Technology, Especially Biotechnology and the Creation of New Medicines, Health Care, Treat Illness, European Union (EU)

Suggested Citation

Conde Gutierrez, Carlos Augusto, An Exam to the System of European Patents, Public Health and the Biotech and Pharmaceutical Industry (Un Examen al Sistema de Patentes Europeo, Salud Pública y la Industria Farmacéutica y Biotecnológica) (Spanish) (November 8, 2010). Revista la Propiedad Inmaterial, No. 14, pp. 49-58, 2010, Available at SSRN: https://ssrn.com/abstract=1705506

Carlos Augusto Conde Gutierrez (Contact Author)

Universidad Externado de Colombia ( email )

Calle 12 # 1-17 este
Calle 12 0 83
Bogota D.C, Cundinamarca 3456
Colombia

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
72
Abstract Views
631
rank
392,449
PlumX Metrics